Results of Phase II trial to assess the efficacy and safety of idelalisib
"
Andrew Davies, MRCP, PhD from University of Southampton, Southampton, UK discusses his participation in the joint symposia regarding high risk chronic lymphocytic leukemia (CLL) and follicular...
Author: VJHemOnc
Added: 06/28/2016
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts